Industry Information|Beijing Key-Bio Biotech Co., Ltd.

Beijing KEY-BIO Biotech Co.,Ltd.

Industry Information

Ludwig Lausanne study shows how tumors turn immune cells into enablers of their growth

A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known as macrophages from destroyers of tumors to supporters of their growth and survival.

View details 2021-11-22
Pay attention to heart failure, and NT proBNP / BNP helps early diagnosis and treatment

The incidence rate of heart failure is increasing with the aging of the population. It is very important for early diagnosis and optimal treatment. Biomarkers of heart failure can assist in the prediction, early diagnosis, prognosis evalsuation and treatment of heart failure. They are very important for the prevention and treatment of heart failure. Natriuretic peptides (NP) is the earliest and most widely used marker of heart failure. It plays an important role in various clinical applications, but its disadvantage is that the specificity is not consistent in different clinical situations. In recent years, various new biomarkers have been coming out, which provide more help for the diagnosis and treatment of heart failure.

View details 2021-06-30
New crown neutralizing antibody quantitative detection, how to use international standard materials?

By June 11, 2021, the number of vaccinations in China had exceeded 860 million doses; Domestic enterprises have long launched various antibody testing products, including total antibody and neutralizing antibody testing. For the evalsuation of vaccine effect, the best method is the detection of neutralizing antibody. However, so far, no study has defined the concentration of neutralizing antibody to protect the new crown, so the current detection is still based on qualitative detection, that is, to judge the presence or absence of antibody.

View details 2021-06-15

1/1

Hot information